{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:31:44Z","timestamp":1793320304351,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ygyno.2009.11.020","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T13:51:25Z","timestamp":1261057885000},"page":"556-562","source":"Crossref","is-referenced-by-count":79,"title":["Ovarian cancer tumor infiltrating T-regulatory (Treg) cells are associated with a metastatic phenotype"],"prefix":"10.1016","volume":"116","author":[{"given":"Jason C.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina S.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly K.","family":"Dressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.11.020_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumor environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.ygyno.2009.11.020_bib2","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2009.11.020_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2009.11.020_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ygyno.2009.11.020_bib5","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2009.11.020_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-008-0583-5","article-title":"Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer","volume":"58","author":"Leffers","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ygyno.2009.11.020_bib7","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1158\/1078-0432.CCR-05-1244","article-title":"The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer","volume":"11","author":"Wolf","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2009.11.020_bib8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1517\/14712590802494022","article-title":"FOXP3+ regulatory T cells as biomarkers in human malignancies","volume":"8","author":"Bignone","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ygyno.2009.11.020_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-065X.2008.00614.x","article-title":"The impact of T-cell immunity on ovarian cancer outcomes","volume":"222","author":"Nelson","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ygyno.2009.11.020_bib10","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1158\/1078-0432.CCR-08-2430","article-title":"Microarray analysis of early stage serous ovarian cancers demonstrates profiles predictive of favorable outcome","volume":"15","author":"Berchuck","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2009.11.020_bib11","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-04-2398","article-title":"Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers","volume":"15","author":"Berchuck","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2009.11.020_bib12","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1073\/pnas.201162998","article-title":"Predicting the clinical status of human breast cancer by using gene expression profiles","volume":"98","author":"West","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2009.11.020_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2008.01.010","article-title":"Intratumoral T cells, tumor-associated macrophages, and regulatory T-cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer","volume":"109","author":"Shah","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.11.020_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3 T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.11.020_bib15","first-page":"779","article-title":"Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors","volume":"2015","author":"Ping","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ygyno.2009.11.020_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2007.01.024","article-title":"Human ovarian carcinoma cells generate CD4+CD25+ regulatory T cells from peripheral CD4+CD25\u2212 T cells through secreting TGF-B","volume":"253","author":"Li","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2009.11.020_bib17","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/0008-5472.CAN-07-0565","article-title":"Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma","volume":"67","author":"Wei","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2009.11.020_bib18","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1158\/0008-5472.CAN-08-4329","article-title":"CCL5-Mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion","volume":"69","author":"Nesbeth","year":"2009","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ygyno.2009.11.020_bib19","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ygyno.2009.11.020_bib20","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2009.11.020_bib21","series-title":"Crowd control: tumor immunology and immunotherapy. The Biology of Cancer. Garland Science","author":"Weinberg","year":"2007"},{"issue":"5","key":"10.1016\/j.ygyno.2009.11.020_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/intimm\/12.5.731","article-title":"DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses","volume":"12","author":"Kronin","year":"2000","journal-title":"Int. Immunol."},{"issue":"10","key":"10.1016\/j.ygyno.2009.11.020_bib23","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2004-03-1214","article-title":"Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation","volume":"104","author":"Xystrakis","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2009.11.020_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/0008-5472.CAN-06-2903","article-title":"Vaccination against the Forkhead family transcription factor Foxp3 enhances tumor immunity","volume":"67","author":"Nair","year":"2007","journal-title":"Cancer Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809009615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809009615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T14:25:09Z","timestamp":1544797509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809009615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0090825809009615"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.11.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}